Suvretta Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.28M | Hold |
716,759
| – | – | 0.1% | 65 |
|
|
2025
Q1 | $3.5M | Hold |
716,759
| – | – | 0.13% | 67 |
|
|
2024
Q4 | $4.82M | Hold |
716,759
| – | – | 0.16% | 63 |
|
|
2024
Q3 | $5.54M | Hold |
716,759
| – | – | 0.18% | 60 |
|
|
2024
Q2 | $4.3M | Hold |
716,759
| – | – | 0.16% | 55 |
|
|
2024
Q1 | $6.46M | Hold |
716,759
| – | – | 0.24% | 58 |
|
|
2023
Q4 | $6.79M | Hold |
716,759
| – | – | 0.31% | 49 |
|
|
2023
Q3 | $8.53M | Hold |
716,759
| – | – | 0.46% | 47 |
|
|
2023
Q2 | $17.6M | Buy |
716,759
+28,000
| +4% | +$686K | 0.94% | 40 |
|
|
2023
Q1 | $21.6M | Buy |
688,759
+338,333
| +97% | +$10.6M | 0.91% | 34 |
|
|
2022
Q4 | $24.7M | Buy |
350,426
+22,874
| +7% | +$1.61M | 1.04% | 35 |
|
|
2022
Q3 | $28.2M | Sell |
327,552
-113,678
| -26% | -$9.79M | 1.17% | 32 |
|
|
2022
Q2 | $36.5M | Buy |
441,230
+300,234
| +213% | +$24.8M | 1.39% | 30 |
|
|
2022
Q1 | $23.4M | Hold |
140,996
| – | – | 0.72% | 45 |
|
|
2021
Q4 | $23.6M | Hold |
140,996
| – | – | 0.46% | 46 |
|
|
2021
Q3 | $12.2M | Hold |
140,996
| – | – | 0.21% | 57 |
|
|
2021
Q2 | $7.66M | Hold |
140,996
| – | – | 0.11% | 83 |
|
|
2021
Q1 | $8.4M | Hold |
140,996
| – | – | 0.12% | 77 |
|
|
2020
Q4 | $7.36M | Buy |
140,996
+85,406
| +154% | +$4.46M | 0.11% | 69 |
|
|
2020
Q3 | $2.69M | Hold |
55,590
| – | – | 0.05% | 75 |
|
|
2020
Q2 | $2.88M | Buy |
55,590
+46,600
| +518% | +$2.41M | 0.06% | 64 |
|
|
2020
Q1 | $392K | Buy |
+8,990
| New | +$392K | 0.01% | 63 |
|